Myanmar Signed Purchasing and Production Agreement for 10 Million Doses of Sinopharm COVID-19 Vaccines (RTF Bulk)

The signing ceremony of the agreement on purchasing and producing Sinopharm COVID-19 vaccine in Myanmar was held at Lotte Hotel, in Mayangon township of Yangon region on 22 December.

During the ceremony, Chairman of the Central Committee for Supervision of COVID-19 Vaccine Production Union Minister for Industry Dr Charlie Than stressed the following points:

· Myanmar had purchased 26 million doses of the Sinopharm vaccine within the year of 2021. Then, people have been vaccinated against COVID-19 using Sinopharm vaccines.

· The Sinopharm COVID-19 vaccine has been shown to have fewer side effects and is more effective. Therefore, efforts were made to purchase the COVID-19 vaccine from Sinopharm CNBG as Ready to Fill Bulk.

· In collaboration with Sinopharm CNBG, we hope to develop not only important vaccines for Myanmar's healthcare sector but also other drugs.

· The acquisition of RTF Bulk to produce 10 million doses of COVID-19 vaccine is a new step in cooperation between Myanmar and the People's Republic of China.

Afterwards, Ambassador Mr Chen Hai of the People's Republic of China to Myanmar emphasized the following points:

· To develop the vaccines produced by Sinopharm CNBG in Myanmar is the first step of cooperation between Myanmar and China.

· China is distributing the COVID-19 vaccines to 120 countries and stepping up to develop COVID-19 medications for treatment.

· Most of the COVID-19 vaccines that have been injected in Myanmar are made in China, and the signing of the RTF Bulk Agreement will greatly assist in the control of the pandemic in Myanmar.

Then, Chairman Mr Jingzhen Liu of Sinopharm Group discussed the followings:

· Sinopharm CNBG is a leading manufacturer and exporter of pharmaceuticals in China. It is engaged in medical treatment and industry and is the second-largest pharmaceutical manufacturer in Asia.

· The World Health Organization (WHO) has approved the emergency use of Sinopharm COVID-19 vaccines produced by the company.

· He also said that he will continue to cooperate in the prevention and control of the COVID-19 pandemic in Myanmar through the virtual system.

Chairman of the Central Committee for Supervision of COVID-19 Vaccine Production Union Minister for Industry, Union Minister for Health, Yangon region Chief Minister, Yangon region Minister for Natural Resources, Director of the Medical Services of the Ministry of Defence, Ambassador of the People's Republic of China to Myanmar, and officials from the Ministry of Health and the Ministry of Industry attended the ceremony.

During the ceremony, it is found that an agreement to purchase 10 million RTF Bulk Doses of Sinopharm COVID-19 vaccine was signed by Managing Director of Myanmar Pharmaceutical Enterprise U Myo Zar Ni Win and Mr. Yang Xiaung Ming on behalf of Sinopharm China National Biotech Group.

  • Myanmar had purchased 26 million doses of the Sinopharm vaccine within the year of 2021. and people have been vaccinated against COVID-19 using Sinopharm vaccines.
  • The Sinopharm COVID-19 vaccine has been shown to have fewer side effects and is more effective. Therefore, efforts were made to purchase the COVID-19 vaccine from Sinopharm CNBG as Ready to Fill Bulk.